wins (Page 2)

hapabapa Moderna (NASDAQ:MRNA) on Tuesday announced a $176M contract from the U.S. government to accelerate the development of messenger-RNA-based vaccines targeting several influenza strains, including the bird flu family of viruses. The company said that the funding channeled through the Biomedical Advanced Research and Development Authority (BARDA) is expected toContinue Reading

designer491/iStock via Getty Images The U.S. FDA has granted marketing authorization to the Xpert HCV test and GeneXpert Xpress System, the first-ever point-of-care test for hepatitis C, from Danaher (NYSE:DHR) subsidiary Cepheid. The test can be performed in places such as doctors’ offices, emergency departments, and urgent care clinics. TheContinue Reading